Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7732882

Concept 2017-04-01 to
2017-09-30
Consolidated statement of income
Statement of income
Net sales
182,683,000 JPY
Cost of sales
177,943,000 JPY
Operating expenses
Selling, general and administrative expenses
690,660,000 JPY
Operating expenses
Operating profit (loss)
-685,920,000 JPY
Gross profit (loss)
4,739,000 JPY
Net sales
Ordinary profit (loss)
-685,187,000 JPY
Operating expenses
Research and development expenses
506,157,000 JPY
Non-operating income
Interest income
23,000 JPY
Other
14,000 JPY
Non-operating income
733,000 JPY
Selling, general and administrative expenses
Cost of sales
Profit (loss) before income taxes
-685,187,000 JPY
Gross profit
Income taxes - current
2,609,000 JPY
Income taxes - deferred
810,000 JPY
Income taxes
3,420,000 JPY
Profit (loss)
-688,607,000 JPY
Profit (loss) attributable to non-controlling interests
-1,274,000 JPY
Profit (loss) attributable to owners of parent
-687,332,000 JPY
Profit attributable to
Comprehensive income
-688,607,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-687,332,000 JPY
Comprehensive income attributable to non-controlling interests
-1,274,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.